The protective role of deferoxamine in the prevention of doxorubicin-induced hepatic fibrosis in children: A randomized controlled clinical trial

نویسندگان
Bordbar, Mohammadreza ID 1
Dehghani, Seyed Mohsen ID 2
Shahriari, Mahdi ID 3
Shakibazad, Nader ID 4
Fathpour, Gholamreza ID 5
Haghpanah, Sezaneh ID 6
Molavi Vardanjani, Hossein ID 7
Fattahi, Mohammadreza ID 8

1 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

2 Medical sciences

3 shiraz uni

4 shiraz uni

5 Hematology Research center, Shiraz University of Medical Sciences, Shiraz, Iran

6 Shiraz Uni

7 Shiraz Uni

8 Shiraz uni

doi
10.58209/ijbc.14.3.1
چکیده

Background: This study aimed to investigate the protective role of deferoxamine (DFO) in the prevention of doxorubicin (DOX)-induced hepatic fibrosis in children. Methods: In this prospective randomized controlled trial, 61 treatment-naïve children (2-18 years) with different types of cancer who referred to a tertiary teaching hospital in the South of Iran ...

کلیدواژه‌ها
Deferoxamine, Doxorubicin, Hepatic fibrosis, Children